Pharma Journalist -

Discovery Life Sciences (Discovery), the biospecimen and biomarker specialists, announced its acquisition of AllCells, a leading provider of clinical-grade (GMP-compliant) and Research…
Read More...

On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T…
Read More...

Bicycle Therapeutics plc announced that Genentech, a member of the Roche Group, has exercised its second option to initiate a new program, expanding the exclusive strategic…
Read More...

Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule therapeutics, announced that it has raised $50 million in a Series D financing round,…
Read More...

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, announced that the U.S. Food and Drug…
Read More...

Thermo Fisher Scientific announced the launch of the Applied Biosystems TaqPath Respiratory Viral Select Panel; a CE-IVD-marked molecular assay panel for detection of five common…
Read More...

Innoviva, Inc. and La Jolla Pharmaceutical Company announced that they have entered into a definitive merger agreement whereby Innoviva will acquire La Jolla. Innoviva has agreed to pay…
Read More...

SAE Media Group reports: The full agenda and speaker line-up is now available for 2nd Annual Biosensors for Medical Wearables conference SAE Media Group proudly announces the 2nd…
Read More...

Arcutis Biotherapeutics, Inc. announced that Health Canada has accepted for review the New Drug Submission (NDS) for roflumilast cream 0.3% for the treatment of plaque psoriasis in…
Read More...

Vertex Pharmaceuticals Incorporated announced that the company has entered into a definitive agreement under which Vertex will acquire ViaCyte, a privately held biotechnology company…
Read More...